Press Releases

Date Title  
Toggle Summary West Announces Third-Quarter Dividend and Participation in Upcoming Investor Conferences
EXTON, Pa. , May 8, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a third-quarter 2019 dividend of $0.15 per share.
West Announces Third-Quarter Dividend and Participation in Upcoming Investor Conferences
EXTON, Pa. , May 8, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a third-quarter 2019 dividend of $0.15 per share.
Toggle Summary West Announces First-Quarter 2019 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , April 25, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2019 and updated full-year 2019 financial guidance.
West Announces First-Quarter 2019 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , April 25, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2019 and updated full-year 2019 financial guidance.
Toggle Summary West Named as a Philadelphia Business Journal 2019 Faces of Philanthropy Honoree
EXTON, Pa. , April 12, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc.  (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's recognition by the Philadelphia Business Journal as a 2019 Faces of Philanthropy award recipient.
West Named as a Philadelphia Business Journal 2019 Faces of Philanthropy Honoree
EXTON, Pa. , April 12, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc.  (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's recognition by the Philadelphia Business Journal as a 2019 Faces of Philanthropy award recipient.
Toggle Summary West to Host First-Quarter 2019 Conference Call
EXTON, Pa. , April 11, 2019 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2019  financial results before the market opens on Thursday, April 25, 2019 ,
West to Host First-Quarter 2019 Conference Call
EXTON, Pa. , April 11, 2019 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2019  financial results before the market opens on Thursday, April 25, 2019 ,
Toggle Summary West Expands Presence in Korea with New Sales Office
SEOUL, South Korea , April 3, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has expanded its presence in the Asia Pacific region with a new sales office in Korea—West
West Expands Presence in Korea with New Sales Office
SEOUL, South Korea , April 3, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has expanded its presence in the Asia Pacific region with a new sales office in Korea—West
Toggle Summary West Opens New Digital Technology Center in Bengaluru, India
BENGALURU, India , March 8, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today officially opened the Company's new Digital Technology Center (DTC) in Bengaluru, India , a regional hub of digital and
West Opens New Digital Technology Center in Bengaluru, India
BENGALURU, India , March 8, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today officially opened the Company's new Digital Technology Center (DTC) in Bengaluru, India , a regional hub of digital and
Toggle Summary West Announces Quarterly Dividend and Share Repurchase Program
EXTON, Pa. , Feb. 21, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc.  (NYSE: WST) today announced that the Company's Board of Directors has approved a second-quarter 2019 dividend of $0.15 per share. The dividend will be paid on May 1, 2019 , to shareholders of record as of April 17, 2019
West Announces Quarterly Dividend and Share Repurchase Program
EXTON, Pa. , Feb. 21, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc.  (NYSE: WST) today announced that the Company's Board of Directors has approved a second-quarter 2019 dividend of $0.15 per share. The dividend will be paid on May 1, 2019 , to shareholders of record as of April 17, 2019
Toggle Summary West Announces Fourth-Quarter and Full-Year 2018 Results
- Conference Call Scheduled for 9 a.m. EST Today - EXTON, Pa. , Feb. 14, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2018 and provided financial guidance for full-year 2019.  Executive Summary
West Announces Fourth-Quarter and Full-Year 2018 Results
- Conference Call Scheduled for 9 a.m. EST Today - EXTON, Pa. , Feb. 14, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2018 and provided financial guidance for full-year 2019.  Executive Summary
Toggle Summary West to Host Fourth-Quarter and Full-Year 2018 Conference Call
EXTON, Pa. , Jan. 31, 2019 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2018 financial results before the market opens on Thursday,
West to Host Fourth-Quarter and Full-Year 2018 Conference Call
EXTON, Pa. , Jan. 31, 2019 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2018 financial results before the market opens on Thursday,
Toggle Summary West Announces Quarterly Dividend and Participation in Upcoming Investor Conference
EXTON, Pa. , Dec. 18, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc.  (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2019 dividend of $0.15 per share. The dividend will be paid on February 6, 2019 , to shareholders of record as of January
West Announces Quarterly Dividend and Participation in Upcoming Investor Conference
EXTON, Pa. , Dec. 18, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc.  (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2019 dividend of $0.15 per share. The dividend will be paid on February 6, 2019 , to shareholders of record as of January
Toggle Summary West Announces Participation in Upcoming November Investor Conferences
EXTON, Pa. , Nov. 1, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its Management Team will present an overview of the Company's business at two investor conferences in November.
West Announces Participation in Upcoming November Investor Conferences
EXTON, Pa. , Nov. 1, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its Management Team will present an overview of the Company's business at two investor conferences in November.
Toggle Summary West Announces Third-Quarter 2018 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , Oct. 25, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2018 and reaffirmed net sales and adjusted-diluted EPS guidance for full-year 2018.  Executive
West Announces Third-Quarter 2018 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , Oct. 25, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2018 and reaffirmed net sales and adjusted-diluted EPS guidance for full-year 2018.  Executive
Toggle Summary West Receives Excellence in Pharma: Corporate Social Responsibility Award at CPhI Worldwide
EXTON, Pa. , Oct. 11, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it has received the 2018 Excellence in Pharma: Corporate Social Responsibility Award.
West Receives Excellence in Pharma: Corporate Social Responsibility Award at CPhI Worldwide
EXTON, Pa. , Oct. 11, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it has received the 2018 Excellence in Pharma: Corporate Social Responsibility Award.
Toggle Summary West to Host Third-Quarter 2018 Conference Call
EXTON, Pa. , Oct. 11, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2018 financial results before the market opens on Thursday, October 25, 2018 ,
West to Host Third-Quarter 2018 Conference Call
EXTON, Pa. , Oct. 11, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2018 financial results before the market opens on Thursday, October 25, 2018 ,
Toggle Summary West Highlights Integrated Solutions Offering and Related Technical and Regulatory Expertise at Upcoming Industry Events
West named as finalist in CPhI Pharma Awards EXTON, Pa. , Oct. 8, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will introduce a new Integrated Solutions Program to help to
West Highlights Integrated Solutions Offering and Related Technical and Regulatory Expertise at Upcoming Industry Events
West named as finalist in CPhI Pharma Awards EXTON, Pa. , Oct. 8, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will introduce a new Integrated Solutions Program to help to
Toggle Summary West's President and CEO Eric M. Green Presented With CEO Connection 2018 Social Impact Award
EXTON, Pa. , Sept. 26, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its President and CEO, Mr. Eric M. Green , has received the CEO Connection's 2018 Social Impact Award.
West's President and CEO Eric M. Green Presented With CEO Connection 2018 Social Impact Award
EXTON, Pa. , Sept. 26, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its President and CEO, Mr. Eric M. Green , has received the CEO Connection's 2018 Social Impact Award.
Toggle Summary West Announces Participation in Upcoming September Investor Conferences
EXTON, Pa. , Aug. 23, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its Management Team will present an overview of the Company's business at three investor conferences in
West Announces Participation in Upcoming September Investor Conferences
EXTON, Pa. , Aug. 23, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its Management Team will present an overview of the Company's business at three investor conferences in
Toggle Summary West Announces Second-Quarter 2018 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , July 26, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2018 and reaffirmed financial guidance for full-year 2018.  Executive Summary Second-quarter
West Announces Second-Quarter 2018 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , July 26, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2018 and reaffirmed financial guidance for full-year 2018.  Executive Summary Second-quarter
Toggle Summary West Celebrates Official Opening of New Global Manufacturing Facility in Waterford, Ireland and the launch of Westar® Select Component Offering
EXTON, Pa. , July 19, 2018 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the official opening of its new Waterford, Ireland facility, a global center of excellence for West's advanced
West Celebrates Official Opening of New Global Manufacturing Facility in Waterford, Ireland and the launch of Westar® Select Component Offering
EXTON, Pa. , July 19, 2018 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the official opening of its new Waterford, Ireland facility, a global center of excellence for West's advanced
Toggle Summary West to Host Second-Quarter 2018 Conference Call
EXTON, Pa. , July 12, 2018 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2018 financial results before the market opens on Thursday, July 26, 2018 ,
West to Host Second-Quarter 2018 Conference Call
EXTON, Pa. , July 12, 2018 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2018 financial results before the market opens on Thursday, July 26, 2018 ,
Toggle Summary West Appoints Bernard Birkett to Chief Financial Officer
EXTON, Pa. , June 21, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has appointed Bernard J. Birkett to serve as Senior Vice President, Chief Financial Officer and Treasurer,
West Appoints Bernard Birkett to Chief Financial Officer
EXTON, Pa. , June 21, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has appointed Bernard J. Birkett to serve as Senior Vice President, Chief Financial Officer and Treasurer,
Toggle Summary West's SelfDose™ Patient-Controlled Injector Wins Silver Medical Design Excellence Award
EXTON, Pa. , June 13, 2018 /PRNewswire/ -- (Booth #1933) -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it has received the Silver Medical Design Excellence Award for "Drug-Delivery and Combination
West's SelfDose™ Patient-Controlled Injector Wins Silver Medical Design Excellence Award
EXTON, Pa. , June 13, 2018 /PRNewswire/ -- (Booth #1933) -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it has received the Silver Medical Design Excellence Award for "Drug-Delivery and Combination
Toggle Summary West Announces Participation in Upcoming June Investor Conferences
EXTON, Pa. , May 24, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its Management Team will present an overview of the Company's business at two investor conferences in June.
West Announces Participation in Upcoming June Investor Conferences
EXTON, Pa. , May 24, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its Management Team will present an overview of the Company's business at two investor conferences in June.
Toggle Summary West Announces Third-Quarter Dividend, Increase to Fourth-Quarter Dividend and Participation in Upcoming Investor Conferences
EXTON, Pa. , May 3, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a third-quarter 2018 dividend of $0.14 per share.  The dividend will be paid on August 1, 2018 , to shareholders of record as of July 18, 2018
West Announces Third-Quarter Dividend, Increase to Fourth-Quarter Dividend and Participation in Upcoming Investor Conferences
EXTON, Pa. , May 3, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a third-quarter 2018 dividend of $0.14 per share.  The dividend will be paid on August 1, 2018 , to shareholders of record as of July 18, 2018
Toggle Summary West Announces First-Quarter 2018 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , April 26, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2018 and reaffirmed financial guidance for full-year 2018.  Executive Summary First-quarter 2018
West Announces First-Quarter 2018 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , April 26, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2018 and reaffirmed financial guidance for full-year 2018.  Executive Summary First-quarter 2018
Toggle Summary West to Host First-Quarter 2018 Conference Call
EXTON, Pa. , April 12, 2018 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2018 financial results before the market opens on Thursday, April 26, 2018 ,
West to Host First-Quarter 2018 Conference Call
EXTON, Pa. , April 12, 2018 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2018 financial results before the market opens on Thursday, April 26, 2018 ,
Toggle Summary West to Showcase DAIKYO PLASCAP® RUV One-Step Press-Fit Vial Closure Solution at PDA Annual Meeting
West to present several scientific posters highlighting expertise in ensuring quality, sterility and stability of injectable drug products ORLANDO, Fla. , March 19, 2018 /PRNewswire/ -- (Booth #501) – West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for
West to Showcase DAIKYO PLASCAP® RUV One-Step Press-Fit Vial Closure Solution at PDA Annual Meeting
West to present several scientific posters highlighting expertise in ensuring quality, sterility and stability of injectable drug products ORLANDO, Fla. , March 19, 2018 /PRNewswire/ -- (Booth #501) – West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for
Toggle Summary West Chief Financial Officer William Federici Announces Plans to Retire
EXTON, Pa. , March 2, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced William Federici , Senior Vice President, Chief Financial Officer and Treasurer, has communicated his intention to
West Chief Financial Officer William Federici Announces Plans to Retire
EXTON, Pa. , March 2, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced William Federici , Senior Vice President, Chief Financial Officer and Treasurer, has communicated his intention to
Toggle Summary West Appoints Silji Abraham Chief Digital and Transformation Officer
EXTON, Pa. , Feb. 26, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced Silji Abraham has been appointed Senior Vice President and Chief Digital and Transformation Officer, and will be
West Appoints Silji Abraham Chief Digital and Transformation Officer
EXTON, Pa. , Feb. 26, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced Silji Abraham has been appointed Senior Vice President and Chief Digital and Transformation Officer, and will be
Toggle Summary West Announces Fourth-Quarter and Full-Year 2017 Results and Announces Quarterly Dividend
- Conference Call Scheduled for 9 a.m. EST Today - EXTON, Pa. , Feb. 15, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2017 and provided financial guidance for full-year 2018.  Executive Summary
West Announces Fourth-Quarter and Full-Year 2017 Results and Announces Quarterly Dividend
- Conference Call Scheduled for 9 a.m. EST Today - EXTON, Pa. , Feb. 15, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2017 and provided financial guidance for full-year 2018.  Executive Summary
Toggle Summary SelfDose™ Patient-Controlled Injector Named as Recipient of Pharmapack Exhibitor Innovation Award
West Pharmaceutical Services, Inc. to showcase SelfDose injector among other advancements in integrated containment and drug delivery at Pharmapack Europe 2018 PARIS , Feb. 7, 2018 /PRNewswire/ -- Booth #D20 -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions
SelfDose™ Patient-Controlled Injector Named as Recipient of Pharmapack Exhibitor Innovation Award
West Pharmaceutical Services, Inc. to showcase SelfDose injector among other advancements in integrated containment and drug delivery at Pharmapack Europe 2018 PARIS , Feb. 7, 2018 /PRNewswire/ -- Booth #D20 -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions
Toggle Summary West to Host Fourth-Quarter and Full-Year 2017 Conference Call
EXTON, Pa. , Feb. 1, 2018 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2017 financial results before the market opens on Thursday,
West to Host Fourth-Quarter and Full-Year 2017 Conference Call
EXTON, Pa. , Feb. 1, 2018 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2017 financial results before the market opens on Thursday,
Toggle Summary West Announces Quarterly Dividend and Participation in Upcoming Investor Conferences
EXTON, Pa. , Dec. 22, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2018 dividend of $0.14 per share. The dividend will be paid on February 1, 2018 , to shareholders of record as of January 18,
West Announces Quarterly Dividend and Participation in Upcoming Investor Conferences
EXTON, Pa. , Dec. 22, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2018 dividend of $0.14 per share. The dividend will be paid on February 1, 2018 , to shareholders of record as of January 18,
Toggle Summary West Announces Upcoming Investor Conference
EXTON, Pa. , Nov. 15, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced that management will be presenting a West business overview at the upcoming Jefferies 2017 London Healthcare Conference ,
West Announces Upcoming Investor Conference
EXTON, Pa. , Nov. 15, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced that management will be presenting a West business overview at the upcoming Jefferies 2017 London Healthcare Conference ,
Toggle Summary West to Showcase New Extensions of the SmartDose® Drug Delivery Platform at the PDA Universe of Pre-filled Syringes and Injection Devices
Company will Lead Educational Sessions and Share Scientific Advances in Integrated Containment and Drug Delivery VIENNA , Nov. 6, 2017 /PRNewswire/ --  (Booth X67) – West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today
West to Showcase New Extensions of the SmartDose® Drug Delivery Platform at the PDA Universe of Pre-filled Syringes and Injection Devices
Company will Lead Educational Sessions and Share Scientific Advances in Integrated Containment and Drug Delivery VIENNA , Nov. 6, 2017 /PRNewswire/ --  (Booth X67) – West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today
Toggle Summary West Announces Third-Quarter 2017 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , Oct. 26, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third quarter of 2017, updated financial guidance for the full-year 2017, introduced sales growth outlook for
West Announces Third-Quarter 2017 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , Oct. 26, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third quarter of 2017, updated financial guidance for the full-year 2017, introduced sales growth outlook for
Toggle Summary West to Host Third-Quarter 2017 Conference Call
EXTON, Pa. , Oct. 12, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2017 financial results before the market opens on Thursday, October 26, 2017 ,
West to Host Third-Quarter 2017 Conference Call
EXTON, Pa. , Oct. 12, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2017 financial results before the market opens on Thursday, October 26, 2017 ,
Toggle Summary Study Demonstrates Benefit of West's ID Adapter for Improving Intradermal Administration of Polio Vaccine
EXTON, Pa. , Oct. 10, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today shared the results of a study highlighting the benefits of West's ID Adapter for improving the intradermal administration of
Study Demonstrates Benefit of West's ID Adapter for Improving Intradermal Administration of Polio Vaccine
EXTON, Pa. , Oct. 10, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today shared the results of a study highlighting the benefits of West's ID Adapter for improving the intradermal administration of
Toggle Summary West Announces Fall Investor Conference Schedule
EXTON, Pa. , Aug. 25, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced that management will be presenting a West business overview at three investor conferences in September.
West Announces Fall Investor Conference Schedule
EXTON, Pa. , Aug. 25, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced that management will be presenting a West business overview at three investor conferences in September.
Toggle Summary West Announces Second-Quarter 2017 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , July 27, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2017 and updated financial guidance for the full-year 2017.
West Announces Second-Quarter 2017 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , July 27, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2017 and updated financial guidance for the full-year 2017.